AU5654798A - Active substance carrier for releasing apomorphine into the buccal cavity - Google Patents

Active substance carrier for releasing apomorphine into the buccal cavity

Info

Publication number
AU5654798A
AU5654798A AU56547/98A AU5654798A AU5654798A AU 5654798 A AU5654798 A AU 5654798A AU 56547/98 A AU56547/98 A AU 56547/98A AU 5654798 A AU5654798 A AU 5654798A AU 5654798 A AU5654798 A AU 5654798A
Authority
AU
Australia
Prior art keywords
apomorphine
releasing
active substance
buccal cavity
substance carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU56547/98A
Other versions
AU746373B2 (en
Inventor
Karsten Cremer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU5654798A publication Critical patent/AU5654798A/en
Application granted granted Critical
Publication of AU746373B2 publication Critical patent/AU746373B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
AU56547/98A 1996-12-16 1997-11-21 Active substance carrier for releasing apomorphine into the buccal cavity Ceased AU746373B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19652268A DE19652268C2 (en) 1996-12-16 1996-12-16 Medicinal preparation for the release of apomorphine in the oral cavity
DE19652268 1996-12-16
PCT/EP1997/006529 WO1998026763A1 (en) 1996-12-16 1997-11-21 Active substance carrier for releasing apomorphine into the buccal cavity

Publications (2)

Publication Number Publication Date
AU5654798A true AU5654798A (en) 1998-07-15
AU746373B2 AU746373B2 (en) 2002-04-18

Family

ID=7814859

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56547/98A Ceased AU746373B2 (en) 1996-12-16 1997-11-21 Active substance carrier for releasing apomorphine into the buccal cavity

Country Status (8)

Country Link
EP (1) EP0959875A1 (en)
JP (1) JP2001506612A (en)
KR (1) KR20000057627A (en)
AU (1) AU746373B2 (en)
CA (1) CA2274893A1 (en)
DE (1) DE19652268C2 (en)
NO (1) NO992944D0 (en)
WO (1) WO1998026763A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803240D0 (en) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US6291471B1 (en) 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males
CA2356533C (en) 1998-12-23 2010-07-13 Mount Sinai School Of Medicine Inhibitors of the bitter taste response
US7314716B2 (en) 1999-11-19 2008-01-01 Mount Sinai School Of Medicine Gustducin γ subunit materials and methods
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
ATE438418T1 (en) 2001-05-01 2009-08-15 Av Topchiev Inst Petrochemical HYDROGEL COMPOSITIONS
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
DE10252726B4 (en) * 2002-11-13 2008-05-08 Lts Lohmann Therapie-Systeme Ag Multilayer transmucosal therapeutic system
AU2003277788A1 (en) * 2002-11-14 2004-06-03 Givaudan Sa Edible film containing food acid
KR100945741B1 (en) * 2003-01-16 2010-03-05 부광약품 주식회사 Oral spray preparation of apomorphine hydrochloride
WO2005074894A1 (en) 2004-01-30 2005-08-18 Corium International Rapidly dissolving film for delivery of an active agent
US20050281757A1 (en) * 2004-06-17 2005-12-22 Sayed Ibrahim Oral care film
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
KR20120042836A (en) * 2009-06-12 2012-05-03 아다지오 파마슈티컬즈 엘티디 Sublingual apomorphine
KR101890317B1 (en) 2010-12-16 2018-08-22 선오비온 파마슈티컬스 인코포레이티드 Sublingual Films
US10806703B2 (en) 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
KR20160108828A (en) * 2013-11-11 2016-09-20 임팩스 라보라토리즈, 인코포레이티드 Rapidly disintegrating formulations and methods of use
CA3019769C (en) 2015-04-21 2021-10-12 Sunovion Pharmaceuticals Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
DE2746414A1 (en) * 1977-10-15 1979-04-26 Gerlach Eduard Chem Fab Foil-like tape for dispensing measured amts. of substance - consisting of the substance, binding agent and adjuvants, tape length being proportional to weight of substance
DE10199068I2 (en) * 1994-04-22 2004-05-06 Pentech Pharmaceuticals Inc Sublingual dosage forms containing apomorphine for use in the treatment of erectile dysfunction.
FR2732896B1 (en) * 1995-04-11 1997-06-13 Prographarm Lab TRANSDERMAL PHARMACEUTICAL FORM FOR PERCUTANEOUS ADMINISTRATION OF APOMORPHINE

Also Published As

Publication number Publication date
AU746373B2 (en) 2002-04-18
EP0959875A1 (en) 1999-12-01
NO992944L (en) 1999-06-16
DE19652268A1 (en) 1998-06-18
KR20000057627A (en) 2000-09-25
CA2274893A1 (en) 1998-06-25
WO1998026763A1 (en) 1998-06-25
DE19652268C2 (en) 2000-06-29
JP2001506612A (en) 2001-05-22
NO992944D0 (en) 1999-06-16

Similar Documents

Publication Publication Date Title
AU5654798A (en) Active substance carrier for releasing apomorphine into the buccal cavity
AU4477597A (en) New pharmaceutically active compounds
AU8262898A (en) Dental isolator
AU7051200A (en) Fly back booster
AU8441798A (en) Tricyclically substituted oxazolidinones
AU6804098A (en) Triazinylaminostilbene compounds
AU2270695A (en) Active compounds
AUPO713297A0 (en) Oxazole compound
AU2080199A (en) New pharmaceutically active compounds
AU6595798A (en) Fragrance precursor compounds
AU1124099A (en) Double ended carrier
AU3950499A (en) Optically active compounds
AU8979698A (en) Solutions containing azasteroids
AU5671099A (en) Compounds having growth hormone releasing activity
ZA963849B (en) Active compound combinations
AU7124598A (en) Polymer-platinum compounds
AUPP042397A0 (en) 5-arylpyrazole compounds
AU6293098A (en) Home-brew device
AU1786799A (en) Composition for the controlled release of active compounds
AU4143397A (en) New pharmaceutically active compounds
AU2488597A (en) Fungicidally active N-acetonylbenzamide compounds
AU8019998A (en) Fluoromethoximino compounds
AU7887300A (en) Buffered phosphorus containing solution
AU5814498A (en) Novel release latch - c-i-p
AU3352297A (en) Controlled release tablets

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired